Related Experiment Videos
Tryptase as severity marker in drug provocation tests
P Komericki1, E Arbab, R Grims
1Department of Environmental Dermatology and Venereology, Medical University Graz, Graz, Austria. peter.komericki@meduni-graz.at
International Archives of Allergy and Immunology
|April 8, 2006
Summary
Serum tryptase levels are not helpful in distinguishing between allergic and "hysterical" drug reactions. Mild reactions showed no consistent increase in tryptase, suggesting limited mast cell activation.
Area of Science:
- Clinical Immunology
- Pharmacology
Background:
- Assessing adverse drug reactions during provocation testing is challenging without objective symptoms.
- Differentiating between true reactions and 'hysterical' (conversion) symptoms is crucial.
Purpose of the Study:
- To evaluate the utility of serum tryptase levels in distinguishing positive, negative, and 'hysterical' drug reactions.
- To determine if serum tryptase changes correlate with reaction severity.
Main Methods:
- A prospective single-center study involving 303 patients and 785 drug provocation tests.
- Serum tryptase levels were measured before and after drug challenge.
- Changes in tryptase were compared between patients with and without objective reactions.
Main Results:
- Thirty-four tests were clinically judged as positive.
- Median serum tryptase levels decreased slightly, though not significantly, in patients with objective symptoms.
- A statistically significant decrease in post-testing tryptase was observed in patients without objective reactions.
Conclusions:
- Serum tryptase measurement is not effective in differentiating mild allergic/nonallergic from 'hysterical' drug reactions.
- A mild decrease in tryptase may suggest minor mast cell activation in some objective reactions.
- More severe reactions correlated with greater mast cell degranulation, while mild reactions did not consistently elevate tryptase.